|
Market Closed -
Nasdaq
16:00:00 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 16.42 USD | -6.17% |
|
-4.20% | - |
| 09-20 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 799M | - | - | - | - | - |
| 74.69B | |||||
| 58.81B | |||||
| 48.45B | |||||
| 42.84B | - | - | - | - | - |
| 42.79B |
Select your edition
All financial news and data tailored to specific country editions
